Literature DB >> 17099084

Falsely raised TSH levels due to human anti-mouse antibody interfering with thyrotropin assay.

S G Santhana Krishnan1, S G S Krishnan, R Pathalapati, L Kaplan, R K Cobbs.   

Abstract

The case of a 39-year-old woman who was referred for weight gain and amenorrhoea is reported. Laboratory evaluation showed high levels of thyroid-stimulating hormone (TSH). The patient was started on increasing doses of levothyroxine for subclinical hypothyroidism. TSH remained persistently raised and the patient became thyrotoxic. Evaluation at another laboratory showed normal levels of TSH, raising the possibility of interfering substances. TSH levels were normalised with the addition of mouse serum to the patient's sample, confirming the presence of human anti-mouse antibodies as the interfering substance in the TSH assay.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17099084      PMCID: PMC2660509          DOI: 10.1136/pmj.2006.049809

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  8 in total

Review 1.  Clinical practice. Subclinical hypothyroidism.

Authors:  D S Cooper
Journal:  N Engl J Med       Date:  2001-07-26       Impact factor: 91.245

Review 2.  Subclinical hypothyroidism is mild thyroid failure and should be treated.

Authors:  M T McDermott; E C Ridgway
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

Review 3.  Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays.

Authors:  Stanley S Levinson; James J Miller
Journal:  Clin Chim Acta       Date:  2002-11       Impact factor: 3.786

4.  Heterophilic antibodies causing falsely raised thyroid-stimulating-hormone result.

Authors:  G Hedenborg; T Pettersson; A Carlström
Journal:  Lancet       Date:  1979-10-06       Impact factor: 79.321

5.  Heterophilic serum antibodies: a cause for falsely elevated serum thyrotropin levels.

Authors:  M D Brennan; G G Klee; C M Preissner; I D Hay
Journal:  Mayo Clin Proc       Date:  1987-10       Impact factor: 7.616

Review 6.  Antibody interference in thyroid assays: a potential for clinical misinformation.

Authors:  N Després; A M Grant
Journal:  Clin Chem       Date:  1998-03       Impact factor: 8.327

7.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Authors:  Joseph G Hollowell; Norman W Staehling; W Dana Flanders; W Harry Hannon; Elaine W Gunter; Carole A Spencer; Lewis E Braverman
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

8.  American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism.

Authors:  H Jack Baskin; Rhoda H Cobin; Daniel S Duick; Hossein Gharib; Richard B Guttler; Michael M Kaplan; Robert L Segal
Journal:  Endocr Pract       Date:  2002 Nov-Dec       Impact factor: 3.443

  8 in total
  4 in total

1.  Treatment-refractory hypothyroidism.

Authors:  Abdulaziz Ramadhan; Michael Tamilia
Journal:  CMAJ       Date:  2011-12-12       Impact factor: 8.262

Review 2.  Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report.

Authors:  M Centanni; S Benvenga; I Sachmechi
Journal:  J Endocrinol Invest       Date:  2017-07-10       Impact factor: 4.256

3.  Does TSH Reliably Detect Hypothyroid Patients?

Authors:  C Ling; Q Sun; J Khang; M Felipa Lastarria; J Strong; B Stolze; X Yu; T P Parikh; M A Waldman; K Welsh; J Jonklaas; L Masika; S J Soldin
Journal:  Ann Thyroid Res       Date:  2018-02-20

Review 4.  Hormone Immunoassay Interference: A 2021 Update.

Authors:  Khaldoun Ghazal; Severine Brabant; Dominique Prie; Marie-Liesse Piketty
Journal:  Ann Lab Med       Date:  2022-01-01       Impact factor: 3.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.